期刊文献+

致死性发育不良Ⅰ型与成纤维细胞生长因子受体-3致病基因 被引量:1

Type Ⅰ of Thanatophoric Dysplasia and Pathogenic Gene of FGFR-3
下载PDF
导出
摘要 致死性发育不良(TD)是一种严重的短肢侏儒症,临床上以四肢短小、胸腔狭窄、脑积水等为特征,是由成纤维细胞生长因子受体-3(FGFR3)基因突变所致。根据患者是否有弯曲的股骨,将TD分为TDⅠ和TDⅡ两种亚型,TDⅠ患者股骨弯曲,伴有或不伴有三叶草头骨,TDⅡ患者有直的股骨,均具有严重的三叶草头骨。本文主要就TDⅠ临床表现,致病基因FGFR3的结构、功能、致病机制和产前诊断的有关进展作一综述。 Thanatophoric dysplasia(TD)is a severe short-limb dwarf disease characterized by short limbs,thoracic stenosis and brain malformation,which is caused by fibroblast growth factor receptor-3(FGFR3)gene mutation.According to whether the patient had bending femur,TD was divided into two subtypes:TDⅠ and TDⅡ.TDⅠ patients had bending femur,with or without clover skull.TDⅡ patients had straight femur,with severe clover skull.This paper mainly reviews the clinical manifestations of TDⅠ,the structure,function,pathogenesis and prenatal diagnosis of FGFR3.
作者 陈畅 鲁艳芹 CHEN Chang;LU Yan-qin(School of Biomedical Science(Provincial Research Center of Medical Biotechnology),Shandong First Medical University(Shandong Academy of Medical Science),Jianan 250117,Shandong Province,China;Department of Endocrinology,the First Affiliated Hospital of Shandong First Mediacal University,Jianan 250014,Shandong Province,China)
出处 《罕少疾病杂志》 2022年第7期5-7,59,共4页 Journal of Rare and Uncommon Diseases
关键词 致死性发育不良Ⅰ型 成纤维生长因子受体-3 产前诊断 Fatal Dysplasia Fibroblast Growth Factor Receptor-3 Prenatal Diagnosis
  • 相关文献

参考文献4

二级参考文献42

  • 1朱娜,王卫庆,姜蕾,叶蕾,方文强,毕宇芳,关黎清,赵咏桔,宁光.先天性软骨发育不全一家系的基因诊断[J].中华内分泌代谢杂志,2004,20(5):441-443. 被引量:7
  • 2麻宏伟,姜俊,吕峻峰,牛国辉,卢瑶,卢丽萍,姚阳,蔡爱露,尚涛,李辉.FGFR3基因突变分析在产前诊断及短肢畸形胎儿中的应用[J].中国实用儿科杂志,2005,20(4):242-243. 被引量:14
  • 3Shiang R, Thompson LM, Zhu YZ, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia [ J ]. Cell, 1994, 78 : 335 - 342.
  • 4Hecht JT, Thompson NM, Weir T, et al. Cognitive and motor skills in achondroplastic infants: neurologic and re- spiratory correlates [ J]. Am J Med Genet, 1991, 41: 208 - 211.
  • 5Francomano CA. The genetic basis of dwarfism [ J]. N En- gl J Med, 1995, 332:58 -59.
  • 6Wynn J, King TM, Gambello M J, et al. Mortality in a- chondroplasia study: a 42-year follow-up [ J]. Am J Med Genet A, 2007, 143A: 2502-2511.
  • 7Perez-Castro AV, Wilson J, Ahherr MR. Genomic organi- zation of the humanf ibroblast growth factor receptor 3 ( FG- FR3 ) gene and comparative sequence analysis with the mouse Fgfr3 geue [J]. Genomics, 1997, 41:10 - 16.
  • 8Keegan K, Johnson DE, Williams LT, et al. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3 [J]. Proc Natl Acad Sci USA, 1991, 88 : 1095 - 1099.
  • 9Matsushita T, Wilcox WR, Chan YY, et al. FGFR3 pro- motes synchondrosis closure and fusion of ossification cen- ters through the MAPK pathway [ J ]. Hum Mol Genet, 2009, 18 : 227 - 240.
  • 10Di Gabriele AD, Lax I, Chen DI, et al. Structure of a heparin-linked biologically active dimer of fibroblast growth factor [J]. Nature, 1998, 393 : 812 -817.

共引文献6

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部